Literature DB >> 16190815

Isolation and characterization of a novel mouse lymphatic endothelial cell line: SV-LEC.

T Ando1, P Jordan, T Joh, Y Wang, M H Jennings, J Houghton, J S Alexander.   

Abstract

BACKGROUND: The lymphatic system regulates interstitial fluid and protein balance and modulates immune responses by regulating leukocyte and antigen traffic to lymph nodes. The present article describes a stable mouse lymphatic endothelial cell line from mesenteric adventitial tissue (SV-LEC) which is distinct from blood aortic (AEC) and venous (VEC) endothelial cells, based on expression of several lymphatic markers (e.g., Prox-1, LYVE-1, Flt-4). SV-LEC also expresses MAdCAM-1 in response to TNF-alpha, an effect seen in VEC, but not AEC. METHODS AND
RESULTS: Lymphatic endothelial cells (SV-LEC) were isolated from mesenteric adventitia from mice expressing temperature-sensitive SV40 large T ('Immortomouse', H-2K(b)tsA58) selected with hypoxia culture in D-valine-substituted MEM supplemented with VEGFC in a low oxygen atmosphere (0% O2, 5% CO2, and 95% N2) with 5 mM thioglycolate. Expression of lymphatic-specific markers (Flt-4, LYVE-1, Prox-1) and the tight junction proteins (ZO-1) were examined by RT-PCR, immunoblotting, and fluorescent microscopy. MAdCAM-1 (a high endothelial venular marker) expression was also examined in response to TNF-alpha IL-1beta and IFN-gamma.
RESULTS: Message for Flt-4 and LYVE-1 was detected on SV-LEC. Immunoblotting for LYVE-1 and Prox-1 showed strong expression on SV-LEC and VEC, but not AEC. Occludin expression was seen in all cell types, junctional ZO-1 was detected at SV-LEC and VEC junctions, not AEC.
CONCLUSION: SV-LEC expresses several lymphatic endothelial markers, some of which are shared with VEC, but not AEC, and may represent a useful system for modeling lymphatic function in vitro.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16190815     DOI: 10.1089/lrb.2005.3.105

Source DB:  PubMed          Journal:  Lymphat Res Biol        ISSN: 1539-6851            Impact factor:   2.589


  33 in total

1.  Murine rVEGF164b, an inhibitory VEGF reduces VEGF-A-dependent endothelial proliferation and barrier dysfunction.

Authors:  Walter Cromer; Merilyn H Jennings; Yoshinubo Odaka; J Michael Mathis; J Steven Alexander
Journal:  Microcirculation       Date:  2010-10       Impact factor: 2.628

2.  Cryptotanshinone inhibits lymphatic endothelial cell tube formation by suppressing VEGFR-3/ERK and small GTPase pathways.

Authors:  Yan Luo; Wenxing Chen; Hongyu Zhou; Lei Liu; Tao Shen; J Steven Alexander; Shizhong Zheng; Yin Lu; Shile Huang
Journal:  Cancer Prev Res (Phila)       Date:  2011-08-31

3.  Ultrasound-based molecular imaging and specific gene delivery to mesenteric vasculature by endothelial adhesion molecule targeted microbubbles in a mouse model of Crohn's disease.

Authors:  José L Tlaxca; Joshua J Rychak; Peter B Ernst; Prasad R Konkalmatt; Talent I Shevchenko; Theresa T Pizarro; Theresa T Pizzaro; Jesús Rivera-Nieves; Alexander L Klibanov; Michael B Lawrence
Journal:  J Control Release       Date:  2012-11-08       Impact factor: 9.776

4.  Culturing purifies murine lymph node lymphatic endothelium.

Authors:  Kimberly L Jordan-Williams; Alanna Ruddell
Journal:  Lymphat Res Biol       Date:  2014-05-16       Impact factor: 2.589

5.  Differential cytokine responses in human and mouse lymphatic endothelial cells to cytokines in vitro.

Authors:  G V Chaitanya; S E Franks; W Cromer; S R Wells; M Bienkowska; M H Jennings; A Ruddell; T Ando; Y Wang; Y Gu; M Sapp; J M Mathis; P A Jordan; A Minagar; J S Alexander
Journal:  Lymphat Res Biol       Date:  2010-09       Impact factor: 2.589

6.  Demonstration of ATP-dependent, transcellular transport of lipid across the lymphatic endothelium using an in vitro model of the lacteal.

Authors:  Alana L Reed; Sydney A Rowson; J Brandon Dixon
Journal:  Pharm Res       Date:  2013-11-20       Impact factor: 4.200

7.  Characterization of cells expressing lymphatic marker LYVE-1 in macaque large intestine during simian immunodeficiency virus infection identifies a large population of nonvascular LYVE-1(+)/DC-SIGN(+) cells.

Authors:  Yang-Kyu Choi; Beth A Fallert Junecko; Cynthia R Klamar; Todd A Reinhart
Journal:  Lymphat Res Biol       Date:  2013-03       Impact factor: 2.589

8.  Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth.

Authors:  Romulo J C Albuquerque; Takahiko Hayashi; Won Gil Cho; Mark E Kleinman; Sami Dridi; Atsunobu Takeda; Judit Z Baffi; Kiyoshi Yamada; Hiroki Kaneko; Martha G Green; Joe Chappell; Jörg Wilting; Herbert A Weich; Satoru Yamagami; Shiro Amano; Nobuhisa Mizuki; Jonathan S Alexander; Martha L Peterson; Rolf A Brekken; Masanori Hirashima; Seema Capoor; Tomohiko Usui; Balamurali K Ambati; Jayakrishna Ambati
Journal:  Nat Med       Date:  2009-08-09       Impact factor: 53.440

9.  Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth.

Authors:  Won Gil Cho; Romulo J C Albuquerque; Mark E Kleinman; Valeria Tarallo; Adelaide Greco; Miho Nozaki; Martha G Green; Judit Z Baffi; Balamurali K Ambati; Massimo De Falco; Jonathan S Alexander; Arturo Brunetti; Sandro De Falco; Jayakrishna Ambati
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-09       Impact factor: 11.205

10.  Myeloid cells contribute to tumor lymphangiogenesis.

Authors:  Adrian Zumsteg; Vanessa Baeriswyl; Natsuko Imaizumi; Reto Schwendener; Curzio Rüegg; Gerhard Christofori
Journal:  PLoS One       Date:  2009-09-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.